Asia Pacific Clinical Trial Supplies Market Size & Outlook

The clinical trial supplies market in Asia Pacific is expected to reach a projected revenue of US$ 2,236.7 million by 2033. A compound annual growth rate of 9% is expected of Asia Pacific clinical trial supplies market from 2026 to 2033.
Revenue, 2025 (US$M)
$1,143.2
Forecast, 2033 (US$M)
$2,236.7
CAGR, 2026 - 2033
9%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific clinical trial supplies market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific clinical trial supplies market highlights

  • The Asia Pacific clinical trial supplies market generated a revenue of USD 1,143.2 million in 2025.
  • The market is expected to grow at a CAGR of 9% from 2026 to 2033.
  • In terms of segment, phase iii was the largest revenue generating phase in 2025.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
  • Country-wise, Japan is expected to register the highest CAGR from 2026 to 2033.


Asia Pacific data book summary

Market revenue in 2025USD 1,143.2 million
Market revenue in 2033USD 2,236.7 million
Growth rate9% (CAGR from 2026 to 2033)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III
Key market players worldwideAlmac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.2% of the global clinical trial supplies market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 2,236.7 million by 2033.

Phase iii was the largest segment with a revenue share of 57.97% in 2025. Horizon Databook has segmented the Asia Pacific clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2021 to 2033.


Asia Pacific is expected to be one of the fastest growing regions in global clinical trial supplies market. The tremendous growth in clinical research is expected to drive growth of clinical trial supplies market in the region, thereby contributing to the growth of global clinical trial supplies market.

The primary factors driving the growth of clinical research in these regions include low cost per patient in Asia Pacific countries and presence of a diverse group of patients that are easy to recruit. According to a survey by Pharma IQ, 60.0% of the respondents consider China and India as potential regions for clinical research in the next five years.

Entry of Almac Group, a global clinical research and manufacturing organization, in Asia Pacific region is a clear indication of growth of clinical trial supplies market in this region. In 2015, Almac Group announced its new clinical trial supply facility and regional headquarters to serve Asia Pacific clients, as 23.0% of the global clinical trials for new biopharmaceutical products are being conducted in this region.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Supplies Market Scope

Clinical trial supplies market segmentation & scope
Phase I
Phase II
Phase III
Others
Manufacturing
Storage & Distribution
Supply Chain Management
Cold Chain
Non-cold Chain
Pharmaceutical
Biologics
Medical Device
Others
Oncology
CNS Diseases
Cardiovascular Diseases
Infectious Disease
Metabolic Disorders
Others

Clinical Trial Supplies Market Companies

Name Profile # Employees HQ Website
KLIFO View profile 101-250 Glostrup, Hovedstaden, Denmark, Europe https://klifo.com/
BioCair View profile 101-250 Cambridge, Massachusetts, United States, North America http://www.biocair.com
Marken View profile 501-1000 Durham, North Carolina, United States, North America https://www.marken.com/
Waldencast PLC Class A View profile 281 10 Bank Street, Suite 560, White Plains, NY, United States, 10606 https://www.waldencast.com
Almac Group View profile 1001-5000 Craigavon, Craigavon, United Kingdom, Europe https://www.almacgroup.com
PCI Technology View profile 11-50 Reston, Virginia, United States, North America https://pcitechnologyservices.com
Sharp Corp View profile 46200 1 Takumi-machi, Sakai-ku, Sakai-shi, Osaka, Japan, 590-8522 https://www.sharp.co.jp
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Asia Pacific clinical trial supplies market size, by country, 2021-2033 (US$M)

Asia Pacific Clinical Trial Supplies Market Outlook Share, 2025 & 2033 (US$M)

Asia Pacific clinical trial supplies market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online